Diagnostics News and Research

RSS

Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer

llumina today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., as Chief Executive Officer, effective September 25, 2023.

5 Sep 2023

Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows

Yourgene Health plc (“Yourgene”), a leading international molecular diagnostics group, today launched the Yourgene® MagBench™ Automated DNA Extraction Instrument and Kit. MagBench solution is available to Sage™ customers across Asia-Pacific and the Middle East.

5 Sep 2023

Thermo Fisher Scientific Announces the Launch of the EXENT® Solution with IVDR Certification

Thermo Fisher Scientific, the world leader in serving science, today announced the commercial launch of the EXENT® Solution, after receiving IVDR certification.

28 Aug 2023

Understanding the Importance of Entrepreneurship in the Life Sciences Community

In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Maciej Grajewski, the Co-Founder and Chief Technology Officer at SG Papertronics, about all things bio-entrepreneurship.

From Society for Laboratory Automation and Screening (SLAS) 28 Aug 2023

New System to Quickly Detect Airborne Viruses Using High-Speed Train Technology

Researchers from University of British Columbia and Michigan State University have invented a system that can quickly and inexpensively detect airborne viruses using the same technology that enables high-speed trains.

24 Aug 2023

Supporting Informed Decisions on Malaria Biocontrol Interventions

Following World Mosquito Day, we spoke with Dr. Michael Santos from GeneConvene Global Collaborative about using genetically engineered mosquitoes to help tackle malaria and how the Collaborative supports informed decision-making regarding this potentially game-changing technique.

21 Aug 2023

Targeting Long-read RNA Sequencing with Low-Cost Technology

Researchers at the Children’s Hospital of Philadelphia (CHOP) have created a flexible and affordable approach for targeted sequencing of full-length RNA molecules, which might hasten the development of novel diagnostics and therapies.

16 Aug 2023

Determining a Network of Cellular Programs Controlling Human Cancers

A Ludwig Cancer Research study has identified a pair of genes whose expression by a type of immune cell within tumors is predictive of outcomes for cancer patients and is linked to a vast network of gene expression programs, engaged by multiple cell types in the tumor microenvironment, that control human cancers.

4 Aug 2023

New Nanopore Technology Can Identify Single-Molecule Protein Variations

A group of researchers guided by the University of Oxford has made significant progress in detecting changes in protein structures. The method, which was published in Nature Nanotechnology, uses novel nanopore technology to detect structural variations at the single-molecule level, even deep within long protein chains.

2 Aug 2023

Mainz Biomed Announces Live Launch of ColoAlert® with Marylebone Laboratory in the United Kingdom

Mainz Biomed NV (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that London-based Marylebone Laboratory (Marylebone Lab Ltd) has introduced ColoAlert®, Mainz Biomed’s flagship product—a highly effective and user-friendly at-home detection test for colorectal cancer (CRC) - to its extensive UK and international customer base.

2 Aug 2023

Archer Further Enhances Biochip gFET Design for Advanced Sensing and Sends to Commercial Foundry Partner

Archer Materials Limited (“Archer”, the “Company”), a semiconductor company advancing the quantum computing and medical diagnostics industries, has developed a next generation biochip fabrication to better detect and control disease samples on a single graphene field effect transistor (“gFET”) design.

1 Aug 2023

New Method Facilitates Early Detection and Localization of Tumors

To help with early tumor diagnosis and tumor localization, researchers have devised a technology that concurrently detects many cancer-specific DNA circulating hallmarks.

26 Jul 2023

PBD Biotech Secures US Patent for Actiphage TB Diagnostic Kit

PBD Biotech developers of Actiphage TB, a ground-breaking phage-based diagnostic for laboratory tuberculosis testing, has today announced it has secured the grant of a US patent for its diagnostic kit. The company is exhibiting in the AACC Clinical Lab Expo on booth #4578.

26 Jul 2023

Self-Collected STI Tests Perform as Well as Provider-Collected Tests

Self-collected tests performed similarly to provider-collected tests for detecting common sexually transmitted infections (STIs), according to research presented today at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo. These findings could enable discreet new testing options that expand access to screening.

26 Jul 2023

Atomic-Level Analysis of Synthetic DNA to Reveal New Treatment Options

West Virginia University researchers can now see synthetic DNA at the atomic level, allowing them to learn how to tweak its structure to improve its scissor-like function.

25 Jul 2023

AMP Releases CYP3A4 and CYP3A5 Genotyping Assay Recommendations

The Association for Molecular Pathology (AMP), the world’s leading professional society for molecular diagnostics, released consensus recommendations today to aid in the design and validation of clinical CYP3A4 and CYP3A5 genotyping assays, encourage standardization of testing across labs, and better patient care.

11 Jul 2023

Diagnostics News and Research

Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer

Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows

Thermo Fisher Scientific Announces the Launch of the EXENT® Solution with IVDR Certification

Understanding the Importance of Entrepreneurship in the Life Sciences Community

New System to Quickly Detect Airborne Viruses Using High-Speed Train Technology

Supporting Informed Decisions on Malaria Biocontrol Interventions

Targeting Long-read RNA Sequencing with Low-Cost Technology

Determining a Network of Cellular Programs Controlling Human Cancers

New Nanopore Technology Can Identify Single-Molecule Protein Variations

Mainz Biomed Announces Live Launch of ColoAlert® with Marylebone Laboratory in the United Kingdom

Archer Further Enhances Biochip gFET Design for Advanced Sensing and Sends to Commercial Foundry Partner

New Method Facilitates Early Detection and Localization of Tumors

PBD Biotech Secures US Patent for Actiphage TB Diagnostic Kit

Self-Collected STI Tests Perform as Well as Provider-Collected Tests

Atomic-Level Analysis of Synthetic DNA to Reveal New Treatment Options

AMP Releases CYP3A4 and CYP3A5 Genotyping Assay Recommendations

EMBL-EBI Launches Pathogens Portal to Enhance Global Pathogen Surveillance

T cells are Sensitive to Genetic Disturbances Within Mitochondrial Power Plants

Camena Bioscience Closes $10m Series A Financing as Demand for DNA Synthesis Technology Increases

New Automated Machine Learning Tool to Design and Interpret Biological Sequences

Lab Automation - Third Edition eBook

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics